Quantum Biopharma (QNTM) Current Assets (2018 - 2026)

Quantum Biopharma (QNTM) has 9 years of Current Assets data on file, last reported at $10.4 million in Q1 2026.

• For the quarter ending Q1 2026, Current Assets rose 4.4% year-over-year to $10.4 million; the trailing twelve-month figure through Mar 2026 stood at $10.4 million (up 4.4% YoY), and the FY2025 full-year result was $6.5 million, down 46.25% from the prior year.
• Current Assets climbed to $10.4 million in Q1 2026, from $6.5 million in the prior quarter.
• In the past five years, Current Assets ranged from a high of $17.9 million in Q4 2022 to a low of $6.5 million in Q4 2025.
• A 5-year average of $10.8 million and a median of $10.3 million in 2025 frame the typical range for Current Assets.
• Across the five-year window, Current Assets sank 61.14% in 2022 and increased 8.73% in 2024, its largest moves.
• Tracing QNTM's Current Assets over 5 years: stood at $17.9 million in 2022, then sank by 37.9% to $11.1 million in 2023, then rose by 8.73% to $12.1 million in 2024, then plunged by 46.25% to $6.5 million in 2025, then surged by 60.06% to $10.4 million in 2026.
• Business Quant data shows QNTM's Current Assets at $10.4 million in Q1 2026, $6.5 million in Q4 2025, and $9.3 million in Q3 2025.